Research Studies
Clinical Trials
| Trial | PI/Additional Investigators | ClinicalTrials.gov Identifier |
|---|---|---|
| Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism | Edward Hsiao | |
| FALKON: Study to Assess the Efficacy and Safety of 2 Dosage Regimens of Oral IPN60130 for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP). | Edward Hsiao | NCT05039515 |
| Rollover Study; Multicentre, Phase III, Open-label Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years with Fibrodysplasia Ossificans Progressiva (FOP) | Edward Hsiao | NCT05027802 |
| Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia (CAHtylast) | Chienying Liu | NCT04490915 |
| D-Thio: Optimizing Care for Older Adults Through Thyroid Hormone Deprescribing | Jen Perkins |
Investigator-Initiated Studies
| Trial | PI/Additional Investigators |
|---|---|
| Human Biospecimen Tissue Bank for the Study of Molecular Mechanisms of Hormonal Disorders (Endocrine Biobank) | Endocrine Division-wide |
| The Gut Microbiome in Human Endocrine diseases | Edward Hsiao |
| The UCSF Biospecimens and Skeletal Tissues for Rare and Orphan Disease Genetics (BSTROnG Biobank) | Edward Hsiao, Kelly Wentworth |
| New onset type 1 diabetes study | Mark Anderson, Zoe Quandt |
| Autoimmune polyendocrine syndrome 1 (APS1) study | Mark Anderson, Zoe Quandt |
| Atypical Diabetes study (in collaboration with U Chicago) | Mark Anderson, Zoe Quandt |
| Immune Checkpoint Inhibitor study | Mark Anderson, Zoe Quandt |
| Inflammation, Diabetes, Ethnicity and Obesity (IDEO) Cohort(NCT03022682) | Diana Alba, Suneil Koliwad |
| Immunologic and fat-associated predictors of insulin resistance in treated HIV | Suneil Koliwad, Peter Hunt, Diana Alba |